Medical Device News Magazine

ORTHO Optix Reader Receives CE Mark and Available in Countries That Accept the CE Mark

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

November 30, 2020

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today announced the CE Mark availability of the semi-automated ORTHO Optix™ Reader, which allows lower-volume transfusion labs to elevate their standard of patient care with the quality of results expected of an automated platform.

Ortho Clinical Diagnostics notes the ORTHO Optix Reader’s high-resolution camera captures color, grayscale, front and back images of each test without operator intervention, which provides objective data for automated results interpretation and eliminates the subjectivity and discrepancies of multiple operators reviewing images by eye.

When paired with the ORTHO™ Workstation, the ORTHO Optix Reader provides a complete semi-automated testing platform for transfusion labs with low- to mid-volume throughput. Because the ORTHO Optix Reader has been shown to deliver 99.9% concordance1 with the fully automated ORTHO VISION® Analyzer, it also offers larger volume labs and health care networks a way to back-up or scale up their operations without having to invest in an additional full-automation analyzer. The concordant and high-resolution images of the ORTHO Optix Reader also help to support the technologist during remote review of results from across the laboratory.

“The ORTHO Optix Reader allows transfusion medicine labs with smaller testing volumes the same high-quality, consistent results demonstrated from the award-winning, fully automated ORTHO VISION Analyzer,” said Bob Stowers, Ortho’s head of transfusion medicine product portfolio. “With the ORTHO Optix Reader now included in Ortho’s comprehensive portfolio of automated and semi-automated solutions, labs of all sizes can customize Ortho’s solutions to optimize their resources without compromising quality and accuracy.”

The ORTHO Optix Reader leverages the same proven ORTHO BioVue® System Column Agglutination Technology as the ORTHO VISION Analyzer and a comprehensive testing menu including antibody panels, selected cells and dilution series.

When connected to the customer’s LIS, column grades and images can be automatically sent for long-term retention of result interpretations, therefore reducing and/or eliminating the need for manual documentation of results. The system audit log and reporting module enhances traceability to help labs stay compliant with accreditations and regulations. It also includes QC management capabilities along with assay and reagent tracking to help standardize lab practices.

The ORTHO Optix Reader is supported by Ortho Care™, Ortho’s award-winning, holistic service and support solution, and is now available in countries that accept CE Mark.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”